AVID RADIOPHARMACEUTICALS, INC.

Basic Information

AVID RADIOPHARMACEUTICALS, INC.
3624 Market Street, 5th Floor
Philadelphia, PA, 19104

Company Profile

n/a

Additional Details

Field Value
DUNS: 170631720
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Development of Radiopharmaceuticals for Imaging Brain Tau Pathology

    Amount: $498,812.00

    DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is the most common cause of dementia in the elderly, with more than 4.5 million Americans currently suffering from the disease. Clinical m ...

    SBIR Phase I 2008 Department of Health and Human Services
  2. 18F-AV-133, A Novel Radiopharmaceutical for Differential Diagnosis of Dementia

    Amount: $498,750.00

    DESCRIPTION (provided by applicant): Dementia, with its most prevalent subforms Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and vascular dementia, is a very substantial medical and so ...

    SBIR Phase I 2008 Department of Health and Human Services
  3. 18F-AV-45 PET Imaging of Amyloid in PD with Cognitive Impairment

    Amount: $507,496.00

    DESCRIPTION (provided by applicant): Dementia associated with PD (PDD) is common (affecting up to 80% of patients long-term) and highly disabling. Informative biomarkers are urgently needed to underst ...

    SBIR Phase I 2008 Department of Health and Human Services
  4. Clinical Evaluation of IMPY SPECT for Diagnosis of Alzheimer's

    Amount: $250,000.00

    DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is the most common cause of dementia in the elderly, with more than 4.5 million Americans currently suffering from the disease. Clinical ...

    STTR Phase I 2007 Department of Health and Human Services
  5. 18F-FP-DTBZ for PET Imaging of Beta Cell Mass in Diabetes

    Amount: $247,050.00

    DESCRIPTION (provided by applicant): Both Type I (T1D) and Type 2 (T2D) diabetes share a common pathophysiology - insufficient beta cell mass (BCM) to meet metabolic demands. Unfortunately, advances i ...

    SBIR Phase I 2007 Department of Health and Human Services
  6. AV1: F-18 Radiopharmaceutical for Imaging Amyloid Plaque

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is the development of radiopharmaceuticals for diagnosis of Alzheimer's disease (AD). The project is driven by the hypothesis ...

    SBIR Phase I 2005 Department of Health and Human Services
  7. Radiopharmaceuticals for Imaging Brain Synuclein

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is the development of radiopharmaceuticals for diagnosis of Dementia with Lewy Bodies (DLB). DLB is the second most common cau ...

    SBIR Phase I 2005 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government